消化管ステント市場：製品別、エンドユーザー別-2025-2030年の世界予測

消化管ステント市場は、2023年に4億3,888万米ドルと評価され、2024年には4億6,435万米ドルに達すると予測され、CAGR 5.89%で成長し、2030年には6億5,542万米ドルに達すると予測されています。

消化管ステントは、消化管の閉塞を開くために設計された医療機器であり、大腸がん、食道がん、胆道がんなどの疾患の管理に重要な役割を果たします。ステントの必要性は、消化管疾患の発生率の増加や世界の高齢化により、低侵襲治療が必要になっていることが背景にあります。これらのステントは、主に病院や外来手術センターで悪性・良性両方の閉塞に適用され、患者に緩和と生活の質の向上をもたらしています。市場の洞察によると、生分解性ステントや薬剤溶出性ステントなどの技術的進歩が、ヘルスケア支出の増加とともに大きな成長要因となっています。さらに、低侵襲手術に対する需要の高まりは、市場拡大の潜在的な機会となっています。これらを活用するための推奨事項としては、ステントのデザインと機能性を高めるための研究開発への投資、ヘルスケアインフラが改善しつつある新興市場での事業拡大などが挙げられます。しかし、ステント留置術の高額な費用、ステント移動などの潜在的な合併症、厳しい規制要件などの制約が市場成長の課題となっています。市場競争力のある価格戦略と償還の課題への対処が、市場浸透には不可欠です。技術革新の分野には、有効性と患者の転帰を高めるために生体適合性とドラッグデリバリー機能を向上させたステントの開発が含まれます。市場は急速な技術シフトと規制当局の監視によって特徴づけられるため、企業が競争力を維持するためには、継続的な技術革新、パートナーシップ、戦略的提携に取り組むことが不可欠です。統合の度合いが高いという市場の性質上、企業は市場シェアを獲得するために差別化された製品に注力する必要があります。特にアジア太平洋とラテンアメリカでは、地域の力学を理解し、地域の需要に合わせたソリューションを提供することが、進化する市場環境の中で成長をさらに促進する戦略的な動きとなります。

市場力学：急速に進化する消化管ステント市場の主要市場インサイトを公開

消化管ステント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 消化器がんの有病率の上昇
  • 高齢者人口の増加と加齢に伴う消化器疾患
  • 低侵襲治療への嗜好の高まり
• 市場抑制要因
  • 消化管ステント留置に伴う合併症
• 市場機会
  • ステント設計分野における技術の進歩
  • 生分解性および薬剤溶出性の開発消化管ステント
• 市場の課題
  • 一部の新興諸国における政府の厳しい法律

ポーターの5つの力：消化管ステント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：消化管ステント市場における外部からの影響の把握

外部マクロ環境要因は、消化管ステント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析消化管ステント市場における競合情勢の把握

消化管ステント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス消化管ステント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、消化管ステント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨消化管ステント市場における成功への道筋を描く

消化管ステント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 消化器がんの罹患率の上昇
    • 高齢化人口の増加と加齢に伴う消化器疾患
    • 低侵襲手術への関心が高まる
  • 抑制要因
    • 消化管ステント留置に伴う合併症
  • 機会
    • ステント設計分野における技術の進歩
    • 生分解性薬剤溶出性薬剤の開発消化管ステント
  • 課題
    • 一部の新興諸国における厳格な政府法
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 消化管ステント市場：製品別

• 胆管および膵臓ステント
• 結腸ステント
• 十二指腸ステント
• 食道ステント

第7章 消化管ステント市場：エンドユーザー別

• 外来手術センター
• 病院

第8章 南北アメリカの消化管ステント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の消化管ステント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの消化管ステント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• B. Braun SE
• Becton, Dickinson, and Company
• Boston Scientific Corporation
• CONMED Corporation
• Cook Group Incorporated
• ELLA-CS, s.r.o.
• Fortis Healthcare Limited
• Hobbs Medical, Inc.
• Medtronic PLC
• Merit Medical Systems
• Micro-Tech（Nanjing）Co., Ltd.
• Olympus Corporation
• Stryker Corporation
• TaeWoong Medical
• W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. GASTROINTESTINAL STENTS MARKET RESEARCH PROCESS
• FIGURE 2. GASTROINTESTINAL STENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. GASTROINTESTINAL STENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. GASTROINTESTINAL STENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GASTROINTESTINAL STENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GASTROINTESTINAL STENTS MARKET DYNAMICS
• TABLE 7. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY BILIARY & PANCREATIC STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COLONIC STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DUODENAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ESOPHAGEAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. CANADA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. CANADA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. INDIA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDIA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. ITALY GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ITALY GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. POLAND GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. POLAND GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. QATAR GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. QATAR GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. GASTROINTESTINAL STENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. GASTROINTESTINAL STENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Gastrointestinal Stents Market was valued at USD 438.88 million in 2023, expected to reach USD 464.35 million in 2024, and is projected to grow at a CAGR of 5.89%, to USD 655.42 million by 2030.

Gastrointestinal stents are medical devices designed to open obstructions in the gastrointestinal tract, providing a crucial role in the management of conditions such as colorectal, esophageal, and biliary cancers. Their necessity hinges on the growing incidence of gastrointestinal diseases and an aging global population, necessitating minimally invasive treatments. These stents are predominantly applied in hospitals and ambulatory surgical centers for both malignant and benign obstructions, offering palliation and improving the quality of life for patients. The market insights reveal that technological advancements, such as biodegradable and drug-eluting stents, along with rising healthcare expenditures, are significant growth factors. Additionally, the increasing demand for minimally invasive procedures presents a potential opportunity for market expansion. Recommendations to capitalize on these include investing in R&D to enhance stent design and functionality, and expanding in emerging markets with improving healthcare infrastructure. However, limitations such as the high cost of stenting procedures, potential complications like stent migration, and stringent regulatory requirements challenge market growth. Competitive pricing strategies and addressing reimbursement challenges are essential for market penetration. Innovation areas include the development of stents with improved biocompatibility and drug delivery capabilities to enhance efficacy and patient outcomes. As the market is characterized by rapid technological shifts and regulatory scrutiny, it is vital for businesses to engage in continuous innovation, partnerships, and strategic alliances to stay competitive. The nature of the market, with its high degree of consolidation, calls for companies to focus on differentiated offerings to capture market share. Understanding regional dynamics and tailoring solutions to meet local demands, particularly in Asia-Pacific and Latin America, are strategic moves that can further drive growth in this evolving market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gastrointestinal Stents Market

The Gastrointestinal Stents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of gastrointestinal cancer
  • Growing geriatric population and age-associated GI disorders
  • Increasing preference for minimally-invasive procedures
• Market Restraints
  • Complications associated with gastrointestinal stent implementation
• Market Opportunities
  • Technological advances in the field of stent design
  • Development of biodegradable and drug-eluting gastrointestinal stents
• Market Challenges
  • Stringent government laws in some developing countries

Porter's Five Forces: A Strategic Tool for Navigating the Gastrointestinal Stents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gastrointestinal Stents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gastrointestinal Stents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gastrointestinal Stents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gastrointestinal Stents Market

A detailed market share analysis in the Gastrointestinal Stents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gastrointestinal Stents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gastrointestinal Stents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gastrointestinal Stents Market

A strategic analysis of the Gastrointestinal Stents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastrointestinal Stents Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, Becton, Dickinson, and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, ELLA-CS, s.r.o., Fortis Healthcare Limited, Hobbs Medical, Inc., Medtronic PLC, Merit Medical Systems, Micro-Tech (Nanjing) Co., Ltd., Olympus Corporation, Stryker Corporation, TaeWoong Medical, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Gastrointestinal Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biliary & Pancreatic Stents, Colonic Stents, Duodenal Stents, and Esophageal Stents.
• Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of gastrointestinal cancer
    • 5.1.1.2. Growing geriatric population and age-associated GI disorders
    • 5.1.1.3. Increasing preference for minimally-invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Complications associated with gastrointestinal stent implementation
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advances in the field of stent design
    • 5.1.3.2. Development of biodegradable and drug-eluting gastrointestinal stents
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government laws in some developing countries
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gastrointestinal Stents Market, by Product

• 6.1. Introduction
• 6.2. Biliary & Pancreatic Stents
• 6.3. Colonic Stents
• 6.4. Duodenal Stents
• 6.5. Esophageal Stents

7. Gastrointestinal Stents Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals

8. Americas Gastrointestinal Stents Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Gastrointestinal Stents Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Gastrointestinal Stents Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. B. Braun SE
• 2. Becton, Dickinson, and Company
• 3. Boston Scientific Corporation
• 4. CONMED Corporation
• 5. Cook Group Incorporated
• 6. ELLA-CS, s.r.o.
• 7. Fortis Healthcare Limited
• 8. Hobbs Medical, Inc.
• 9. Medtronic PLC
• 10. Merit Medical Systems
• 11. Micro-Tech (Nanjing) Co., Ltd.
• 12. Olympus Corporation
• 13. Stryker Corporation
• 14. TaeWoong Medical
• 15. W. L. Gore & Associates, Inc.